Background People who inject drugs (PWID) are at increased risk for HIV and hepatitis C
virus (HCV) infection and also have high levels of homelessness and unstable housing. We …

Aims To estimate the effects of needle and syringe programmes (NSP) and opioid
substitution therapy (OST), alone or in combination, for preventing acquisition of hepatitis C …

Objectives. To compare US trends in rates of injection drug use (IDU), specifically opioid
injection, with national trends in the incidence of acute HCV infection to assess whether …

Needle syringe programmes and opioid substitution therapy for preventing hepatitis C
transmission in people who inject drugs - Platt, L - 2017 | Cochrane Library Skip to Content …

Hepatitis C virus (HCV) is a major cause of liver disease worldwide and a potential cause of
substantial morbidity and mortality in the future. The complexity and uncertainty related to …

Globally, hepatitis C virus (HCV) has infected an estimated 130 million people, most of
whom are chronically infected. HCV-infected people serve as a reservoir for transmission to …

Background: Defining the primary characteristics of persons infected with hepatitis C virus
(HCV) enables physicians to more easily identify persons who are most likely to benefit from …

Worldwide, hepatitis B virus (HBV) accounts for an estimated 370 million chronic infections,
hepatitis C virus (HCV) for an estimated 130 million, and HIV for an estimated 40 million. In …

Background Measuring the incidence of HIV and hepatitis C virus (HCV) infection among
people who inject drugs (PWID) is key to track progress towards elimination. We aimed to …

BACKGROUND: Prescription opioids are the most frequently misused class of prescription
drugs amongst young adults. Initiation into prescription opioid misuse is an important public …